CAROLYN GAULDEN: Open Payments
NPI 1831689827 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 12 payments from 8 companies in 2025. Trend: 2023 $217 · 2024 $892 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $149 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 3 | $81 |
| Novo Nordisk Inc | 2 | $53 |
| Dynavax Technologies Corporation | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: INGREZZA, Auvelity, VRAYLAR, Ozempic, Heplisav-B, UZEDY, Cologuard Collection Kit, CAPVAXIVE.
Industry payments across FL — which companies pay providers there.
